Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific

References

• Hutvagner G, Simard MJ. Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol 2008; 105:512 - 517
   Google Scholar
• Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Mol Cell 2007; 26:611 - 623
   PubMed Web of Science ®Google Scholar
• Miyoshi K, Uejima H, Nagami-Okada T, Siomi H, Siomi MC. In vitro RNA cleavage assay for Argonautefamily proteins. Methods Mol Biol 2008; 442:29 - 43
   PubMedGoogle Scholar
• Jagannath A, Wood MJ. Localization of Double-stranded siRNA to Cytoplasmic P-Bodies Is Ago2dependent and Results in Upregulation of GW182 and Ago2. Mol Biol Cell 2008;
   PubMedGoogle Scholar
• Qi HH, Ongusaha PP, Myllyharju J, Cheng D, Pakkanen O, Shi Y, et al. Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature 2008;
   Web of Science ®Google Scholar
• Morris KV, Santoso S, Turner AM, Pastori C, Hawkins PG. Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet 2008; 4:1000258
   PubMed Web of Science ®Google Scholar
• Malecova B, Morris KV. Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs. Curr Opin Mol Ther 2010; 12:214 - 222
   Google Scholar
• Sibley CR, Seow Y, Wood MJ. Novel RNA-based strategies for therapeutic gene silencing. Mol Ther 2010; 18:466 - 476
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kelleher AD. Transcriptional regulation by promoter targeted RNAs. Curr Top Med Chem 2009; 9:1079 - 1087
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kelleher AD. Lessons from viral latency in T cells: manipulating HIV-1 transcription by siRNA. HIV Therapy 2010; 4:199 - 213
   Google Scholar
• Moses J, Goodchild A, Rivory LP. Intended transcriptional silencing with siRNA results in gene repression through sequence-specific off-targeting. RNA 2010; 16:430 - 441
   PubMed Web of Science ®Google Scholar
• Weinberg MS, Barichievy S, Schaffer L, Han J, Morris KV. An RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activation. Nucleic Acids Res 2007; 35:1 - 10
   PubMed Web of Science ®Google Scholar
• Olejniczak M, Galka P, Krzyzosiak WJ. Sequencenon-specific effects of RNA interference triggers and microRNA regulators. Nucleic Acids Res 2010; 38:1 - 16
   PubMed Web of Science ®Google Scholar
• Reynolds A, Anderson EM, Vermeulen A, Fedorov Y, Robinson K, Leake D, et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 2006; 12:988 - 993
   PubMed Web of Science ®Google Scholar
• Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005; 23:457 - 462
   PubMed Web of Science ®Google Scholar
• Kim DH, Longo M, Han Y, Lundberg P, Cantin E, Rossi JJ. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 2004; 22:321 - 325
   PubMed Web of Science ®Google Scholar
• de Veer MJ, Sledz CA, Williams BR. Detection of foreign RNA: implications for RNAi. Immunol Cell Biol 2005; 83:224 - 228
   PubMed Web of Science ®Google Scholar
• Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003; 5:834 - 839
   PubMed Web of Science ®Google Scholar
• Tian B, Mathews MB. Functional characterization of and cooperation between the double-stranded RNA-binding motifs of the protein kinase PKR. J Biol Chem 2001; 276:9936 - 9944
   PubMed Web of Science ®Google Scholar
• Su Q, Wang S, Baltzis D, Qu LK, Wong AH, Koromilas AE. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. Proc Natl Acad Sci USA 2006; 103:63 - 68
   PubMed Web of Science ®Google Scholar
• Suzuki K, Shijuuku T, Fukamachi T, Zaunders J, Guillemin G, Cooper D, Kelleher A. Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter regiony. J RNAi and Gene Silencing 2005; 1:66 - 78
   PubMedGoogle Scholar
• Lim HG, Suzuki K, Cooper DA, Kelleher AD. Promoter-targeted siRNAs Induce Gene Silencing of Simian Immunodeficiency Virus (SIV) Infection In Vitro. Mol Ther 2008; 16:565 - 570
   PubMed Web of Science ®Google Scholar
• Suzuki K, Juelich T, Lim H, Ishida T, Watanebe T, Cooper DA, et al. Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region. J Biol Chem 2008; 283:23353 - 23363
   PubMed Web of Science ®Google Scholar
• Yamagishi M, Ishida T, Miyake A, Cooper DA, Kelleher AD, Suzuki K, Watanabe T. Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription. Microbes Infect 2009; 11:500 - 508
   PubMed Web of Science ®Google Scholar
• Davis S, Propp S, Freier SM, Jones LE, Serra MJ, Kinberger G, et al. Potent inhibition of microRNA in vivo without degradation. Nucleic Acids Res 2009; 37:70 - 77
   Google Scholar
• Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction: twenty-something years on. Nat Protoc 2006; 1:581 - 585
   PubMed Web of Science ®Google Scholar
• Tiscornia G, Singer O, Verma IM. Design and cloning of lentiviral vectors expressing small interfering RNAs. Nat Protoc 2006; 1:234 - 240
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550 - 553
   PubMed Web of Science ®Google Scholar
• Frankova D, Zidek Z. IFN gamma-induced TNFalpha is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFN gamma. Eur J Immunol 1998; 28:838 - 843
   PubMed Web of Science ®Google Scholar
• Kuribayashi K, Krigsfeld G, Wang W, Xu J, Mayes PA, Dicker DT, et al. TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death. Cancer Biol Ther 2008; 7:2034 - 2038
   PubMed Web of Science ®Google Scholar
• Lenz P, Bacot SM, Frazier-Jessen MR, Feldman GM. Nucleoporation of dendritic cells: efficient gene transfer by electroporation into human monocyte-derived dendritic cells. FEBS Lett 2003; 538:149 - 154
   PubMed Web of Science ®Google Scholar
• Landi A, Babiuk LA, van Drunen Littel-van den Hurk S. High transfection efficiency, gene expression and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J Leukoc Biol 2007; 82:849 - 860
   PubMed Web of Science ®Google Scholar
• Verdel A, Jia S, Gerber S, Sugiyama T, Gygi S, Grewal SI, Moazed D. RNAi-mediated Targeting of Heterochromatin by the RITS Complex. Science 2004; 303:672 - 676
   PubMed Web of Science ®Google Scholar
• Motamedi MR, Verdel A, Colmenares SU, Gerber SA, Gygi SP, Moazed D. Two RNAi complexes, RITS and RDRC, physically interact and localize to noncoding centromeric RNAs. Cell 2004; 119:789 - 802
   PubMed Web of Science ®Google Scholar
• Montano MA, Kripke K, Norina CD, Achacoso P, Herzenberg LA, Roy AL, Nolan GP. NFkappaB homodimer binding within the HIV-1 initiator region and interactions with TFII-I. Proc Natl Acad Sci USA 1996; 93:12376 - 12381
   PubMed Web of Science ®Google Scholar
• Kashanchi F, Shibata R, Ross EK, Brady JN, Martin MA. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA. J Virol 1994; 68:3298 - 3307
   PubMed Web of Science ®Google Scholar
• Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA 2004; 101:1892 - 897
   PubMed Web of Science ®Google Scholar
• Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003; 21:635 - 637
   PubMed Web of Science ®Google Scholar
• Jackson AL, Burchard J, Schelter J, Chau BN, Cleary M, Lim L, Linsley PS. Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. RNA 2006; 12:1179 - 1187
   PubMed Web of Science ®Google Scholar
• Cullen BR. Enhancing and confirming the specificity of RNAi experiments. Nat Methods 2006; 3:677 - 681
   PubMed Web of Science ®Google Scholar
• Weinberg MS, Villeneuve LM, Ehsani A, Amarzguioui M, Aagaard L, Chen ZX, et al. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 2006; 12:256 - 262
   PubMed Web of Science ®Google Scholar
• Barichievy S, Saayman S, von Eije KJ, Morris KV, Arbuthnot P, Weinberg MS. The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5′ long terminal repeat. Oligonucleotides 2007; 17:419 - 431
   PubMed Web of Science ®Google Scholar
• Castanotto D, Tommasi S, Li M, Li H, Yanow S, Pfeifer GP, Rossi JJ. Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells. Mol Ther 2005; 12:179 - 183
   PubMed Web of Science ®Google Scholar
• Janowski BA, Huffman KE, Schwartz JC, Ram R, Hardy D, Shames DS, et al. Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat Chem Biol 2005; 1:216 - 222
   PubMed Web of Science ®Google Scholar
• Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, Hartmann R, et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 2006; 24:559 - 565
   PubMed Web of Science ®Google Scholar
• Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 2005; 348:1079 - 1090
   PubMed Web of Science ®Google Scholar
• Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7mediated recognition of single-stranded RNA. Science 2004; 303:1529 - 1531
   PubMed Web of Science ®Google Scholar
• Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, et al. Sequence-specific potent induction of IFN alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005; 11:263 - 270
   PubMed Web of Science ®Google Scholar
• Diebold SS, Massacrier C, Akira S, Paturel C, Morel Y, Reis e Sousa C. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol 2006; 36:3256 - 3267
   PubMed Web of Science ®Google Scholar
• Goodchild A, Nopper N, King A, Doan T, Tanudji M, Arndt GM, et al. Sequence determinants of innate immune activation by short interfering RNAs. BMC Immunol 2009; 10:40
   PubMed Web of Science ®Google Scholar
• Konstantinova P, de Vries W, Haasnoot J, ter Brake O, de Haan P, Berkhout B. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther 2006; 13:1403 - 1413
   PubMed Web of Science ®Google Scholar
• Akashi H, Miyagishi M, Yokota T, Watanabe T, Hino T, Nishina K, et al. Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol Biosyst 2005; 1:382 - 390
   PubMed Web of Science ®Google Scholar
• Saayman S, Barichievy S, Capovilla A, Morris KV, Arbuthnot P, Weinberg MS. The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA. PLoS ONE 2008; 3:2602
   PubMed Web of Science ®Google Scholar
• Robbins MA, Li M, Leung I, Li H, Boyer DV, et al. Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat Biotechnol 2006; 24:566 - 571
   PubMed Web of Science ®Google Scholar
• Heidel JD, Hu S, Liu XF, Triche TJ, Davis ME. Lack of interferon response in animals to naked siRNAs. Nat Biotechnol 2004; 22:1579 - 1582
   PubMed Web of Science ®Google Scholar
• Vaishnaw AK, Gollob J, Gamba-Vitalo C, Hutabarat R, Sah D, Meyers R, et al. A status report on RNAi therapeutics. Silence 2010; 1:14
   PubMedGoogle Scholar
• Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123 - 126
   PubMed Web of Science ®Google Scholar
• Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167 - 1170
   PubMed Web of Science ®Google Scholar
• Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span and viral generation time. Science 1996; 271:1582 - 1586
   PubMed Web of Science ®Google Scholar
• Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, et al. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337:734 - 739
   PubMed Web of Science ®Google Scholar
• Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. AIDS Clinical Trials Group 320 Study Team. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337:725 - 733
   PubMed Web of Science ®Google Scholar
• Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387:188 - 191
   PubMed Web of Science ®Google Scholar
• Palella FJJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853 - 860
   PubMed Web of Science ®Google Scholar
• Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, Siliciano RF. In vivo fate of HIV-1infected T cells: quantitative analysis of the transition to stable latency. Nat Med 1995; 1:1284 - 1290
   PubMed Web of Science ®Google Scholar
• Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387:183 - 188
   PubMed Web of Science ®Google Scholar
• Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295 - 1300
   PubMed Web of Science ®Google Scholar
• Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003; 9:1131 - 1137
   PubMed Web of Science ®Google Scholar
• Lavergne E, Combadiere C, Iga M, Boissonnas A, Bonduelle O, Maho M, et al. Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration. J Immunol 2004; 173:3755 - 3762
   PubMed Web of Science ®Google Scholar
• Riou C, Yassine-Diab B, Van grevenynghe J, Somogyi R, Greller LD, Gagnon D, et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med 2007; 204:79 - 91
   PubMed Web of Science ®Google Scholar
• Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999; 5:512 - 517
   PubMed Web of Science ®Google Scholar
• Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003; 9:727 - 728
   PubMed Web of Science ®Google Scholar
• Strain MC, Gunthard HF, Havlir DV, Ignacio CC, Smith DM, Leigh-Brown AJ, et al. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci USA 2003; 100:4819 - 4824
   PubMed Web of Science ®Google Scholar
• Suzuki K, Craddock BP, Okamoto N, Kano T, Steigbigel RT. Poly A-Linked Colorimetric Microtiter Plate Assay For HIV Reverse Transcriptase. J Virol Methods 1993; 44:189 - 198
   PubMed Web of Science ®Google Scholar
• Suzuki K, Craddock BP, Kano T, Steigbigel RT. Chemiluminescent enzyme-linked immunoassay for reverse transcriptase, illustrated by detection of HIV reverse transcriptase. Anal Biochem 1993; 210:277 - 281
   PubMed Web of Science ®Google Scholar
• Suzuki K, Saito T, Kondo M, Osanai M, Watanabe S, Kano T, et al. Poly A-linked non-isotopic microtiter plate reverse transcriptase assay for sensitive detection of clinical human immunodeficiency virus isolates. J Virol Methods 1995; 55:347 - 356
   PubMed Web of Science ®Google Scholar
• Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 2005; 42:702 - 710
   PubMed Web of Science ®Google Scholar
• Espert L, Rey C, Gonzalez L, Degols G, Chelbi-Alix MK, Mechti N, Gongora C. The exonuclease ISG20 is directly induced by synthetic dsRNA via NFkappaB and IRF1 activation. Oncogene 2004; 23:4636 - 4640
   PubMed Web of Science ®Google Scholar
• Christensen HS, Daher A, Soye KJ, Frankel LB, Alexander MR, Laine S, et al. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production. J Virol 2007; 81:5121 - 5131
   PubMedGoogle Scholar
• Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 upregulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009; 69:1279 - 1283
   PubMed Web of Science ®Google Scholar